HomeCompareSMFR vs XYLD

SMFR vs XYLD: Dividend Comparison 2026

SMFR yields 643.92% · XYLD yields 10.98%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SMFR wins by $457922.45M in total portfolio value
10 years
SMFR
SMFR
● Live price
643.92%
Share price
$0.31
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$457922.48M
Annual income
$350,764,431,454.41
Full SMFR calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
10.98%
Share price
$39.13
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$3,219.02
Full XYLD calculator →

Portfolio growth — SMFR vs XYLD

📍 SMFR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSMFRXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SMFR + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SMFR pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SMFR
Annual income on $10K today (after 15% tax)
$54,732.78/yr
After 10yr DRIP, annual income (after tax)
$298,149,766,736.25/yr
XYLD
Annual income on $10K today (after 15% tax)
$933.63/yr
After 10yr DRIP, annual income (after tax)
$2,736.17/yr
At 15% tax rate, SMFR beats the other by $298,149,764,000.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SMFR + XYLD for your $10,000?

SMFR: 50%XYLD: 50%
100% XYLD50/50100% SMFR
Portfolio after 10yr
$228961.25M
Annual income
$175,382,217,336.71/yr
Blended yield
76.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SMFR right now

SMFR
Analyst Ratings
2
Buy
2
Hold
Consensus: Buy
Price Target
$2.33
+650.2% upside vs current
Range: $1.00 — $3.00
Altman Z
-1.9
Piotroski
5/9
XYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SMFR buys
0
XYLD buys
0
No recent congressional trades found for SMFR or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSMFRXYLD
Forward yield643.92%10.98%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$457922.48M$25.3K
Annual income after 10y$350,764,431,454.41$3,219.02
Total dividends collected$449105.80M$19.6K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: SMFR vs XYLD ($10,000, DRIP)

YearSMFR PortfolioSMFR Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$75,092$64,391.50$10,818$1,098.39+$64.3KSMFR
2$532,241$451,892.93$11,738$1,222.51+$520.5KSMFR
3$3,562,928$2,993,430.52$12,774$1,364.64+$3.55MSMFR
4$22,540,026$18,727,693.09$13,944$1,527.86+$22.53MSMFR
5$134,843,380$110,725,551.39$15,270$1,715.87+$134.83MSMFR
6$763,351,740$619,069,323.81$16,775$1,933.09+$763.33MSMFR
7$4,092,082,536$3,275,296,174.56$18,490$2,184.87+$4092.06MSMFR
8$20,787,693,434$16,409,165,120.49$20,450$2,477.63+$20787.67MSMFR
9$100,147,705,392$77,904,873,416.94$22,697$2,819.19+$100147.68MSMFR
10$457,922,476,223$350,764,431,454.41$25,280$3,219.02+$457922.45MSMFR

SMFR vs XYLD: Complete Analysis 2026

SMFRStock

Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services. It also offers Sema4 Signal that enables and advances precision oncology care, from prevention to treatment to remission; and testing for carrier screening, noninvasive prenatal testing, and newborn screening, as well as hereditary cancer testing. In addition, the company provides COVID-19 testing solutions. Sema4 Holdings Corp. was incorporated in 2020 and is headquartered in Stamford, Connecticut.

Full SMFR Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this SMFR vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SMFR vs SCHDSMFR vs JEPISMFR vs OSMFR vs KOSMFR vs MAINSMFR vs QYLDSMFR vs JEPQSMFR vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.